LivaNova PLC | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
136
123
120
48
96
47
Total Accounts Receivable
39
56
272
245
300
257
Inventories
18
18
212
136
149
154
Other Current Assets
14
24
69
384
324
76
Total Current Assets
207
220
673
813
870
533
Net Property, Plant & Equipment
29
40
245
204
192
191
Total Investments and Advances
11
16
77
59
38
27
Long-Term Note Receivable
-
-
-
2
1
-
Intangible Assets
9
12
1,404
1,133
1,320
1,727
Other Assets
-
1
5
126
71
2
Total Assets
264
294
2,559
2,343
2,504
2,550
ST Debt & Current Portion LT Debt
-
-
83
48
84
Accounts Payable
8
8
110
72
86
Income Tax Payable
-
-
27
18
13
Other Current Liabilities
21
22
140
212
223
Total Current Liabilities
29
30
359
350
406
Long-Term Debt
-
-
92
75
62
Provision for Risks & Charges
4
4
48
22
30
Deferred Taxes
8
6
82
147
112
Other Liabilities
2
1
13
32
66
Total Liabilities
34
35
747
632
688
Common Equity (Total)
230
259
1,811
1,707
1,815
Total Shareholders' Equity
230
259
1,811
1,707
1,815
Total Equity
230
259
1,811
1,707
1,815
Liabilities & Shareholders' Equity
264
294
2,559
2,343
2,504
Non-Equity Reserves
-
-
-
4
1

About LivaNova

View Profile
Address
20 Eastbourne Terrace
London Greater London W2 6LG
United Kingdom
Employees -
Website http://www.livanova.com
Updated 07/08/2019
LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the Cardiac Surgery and Neuromodulation, and Other Corporate segments. The Cardiac Surgery and Neuromodulation segment corresponds to the primary therapeutic areas.